论文部分内容阅读
在我院近年收治的肾病综合征患者中,有12例患者因使用烷化剂而出现了出血性膀胱炎,本文就其发病特点、诊断及治疗作浅析。临床资料1.一般资料:男7例,女5例;年龄16～50岁,平均28±2.1岁。12例患者均符合原发性肾病综合征的诊断标准,并除外了紫癜性仔炎和感染、肿瘤、结石等所致肾损害。其中肾病综合征Ⅰ型10例,Ⅱ型2例。2.烷化剂用法及用量:12例患者所用烷化剂均
In our hospital admitted to patients with nephrotic syndrome in recent years, 12 patients due to the use of alkylating agents and hemorrhagic cystitis, this article on its incidence, diagnosis and treatment for the analysis. Clinical data 1. General information: 7 males and 5 females; aged 16 to 50 years, mean 28 ± 2.1 years. All 12 patients met the diagnostic criteria of primary nephrotic syndrome, with the exception of purpuric inflammation and infection, neoplasms, stones and other kidney damage. Nephrotic syndrome which type Ⅰ in 10 cases, type Ⅱ in 2 cases. 2. alkylating agent usage and dosage: alkylating agent used in 12 patients were